price
AK
NASDAQ · AKTS
Aktis Oncology, Inc.
Healthcare · Biotechnology
$14.94
Up+$0.26 (+1.74%)
Updated Nov 5, 2026, 12:56 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.06B
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $0.03 – $34.19
- Volume
- 579.7K
- Avg. volume
- 374.39K
Price performance · AKTS
AKTS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
AKTS closed at $14.94 after 20 trading sessions, down 17.00% for the selected period.
- Last close
- $14.94
- Period change
- -17.00%
- Period low
- $14.59
- Period high
- $18.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $14.76 | $15.135 | $14.39 | $14.94 | 579.7K |
| Nov 2, 2026 | $16.01 | $16.01 | $13.96 | $14.59 | 898.18K |
| Oct 30, 2026 | $16.84 | $17.07 | $15.77 | $15.93 | 251.54K |
| Oct 29, 2026 | $16.97 | $17.33 | $16.61 | $16.85 | 245.68K |
| Oct 28, 2026 | $16.36 | $17.00 | $16.11 | $16.82 | 193.11K |
| Oct 27, 2026 | $15.70 | $16.69 | $15.59 | $16.45 | 324.71K |
| Oct 26, 2026 | $15.83 | $16.14 | $15.60 | $15.73 | 150K |
| Oct 23, 2026 | $16.50 | $16.61 | $15.6521 | $15.73 | 241.76K |
| Oct 22, 2026 | $16.34 | $16.78 | $16.0216 | $16.76 | 186.97K |
| Oct 21, 2026 | $16.09 | $16.64 | $15.98 | $16.42 | 390.68K |
| Oct 20, 2026 | $15.14 | $16.20 | $15.0001 | $16.08 | 344.06K |
| Oct 19, 2026 | $15.19 | $15.32 | $14.84 | $15.11 | 353.42K |
| Oct 16, 2026 | $16.04 | $16.373 | $14.835 | $15.06 | 394.8K |
| Oct 15, 2026 | $16.65 | $17.075 | $15.765 | $16.01 | 667.74K |
| Oct 14, 2026 | $16.50 | $17.125 | $16.22 | $16.49 | 621.85K |
| Oct 13, 2026 | $17.26 | $17.61 | $16.60 | $16.64 | 327.86K |
| Oct 12, 2026 | $18.12 | $18.19 | $17.31 | $17.34 | 274.07K |
| Oct 9, 2026 | $17.74 | $18.21 | $17.585 | $18.15 | 361.04K |
| Oct 8, 2026 | $17.86 | $17.96 | $16.99 | $17.74 | 500.84K |
| Oct 7, 2026 | $17.72 | $18.35 | $17.70 | $18.00 | 294.1K |
Latest AKTS news
The latest Smart Investors Daily articles mentioning AKTS.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

